Literature DB >> 20084527

The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.

Jun-ichi Takino1, Yuka Kobayashi, Masayoshi Takeuchi.   

Abstract

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a feature of metabolic syndrome. Advanced glycation end-products (AGEs) are formed by the Maillard reaction, which contributes to aging and to certain pathological complications of diabetes. A recent study has suggested that glyceraldehyde-derived AGEs (Glycer-AGEs) are elevated in the sera of patients with NASH. Furthermore, immunohistochemistry of Glycer-AGEs showed intense staining in the livers of patients with NASH. The present study aimed to examine the effect of intracellular Glycer-AGEs on hepatocellular carcinoma (Hep3B) cells.
METHODS: Cell viability was determined by the WST-1 assay. The slot blot and Western blot were used to detect intracellular Glycer-AGEs, and their localization was analyzed by confocal microscopy. Real-time reverse transcription-polymerase chain reaction was used to quantify the mRNA for the acute phase reactant C-reactive protein (CRP).
RESULTS: Glyceraldehyde (GA), which is the precursor of Glycer-AGEs, induced a concentration- and time-dependent increase in cell death, which was associated with an increase in intracellular Glycer-AGEs formation. Aminoguanidine (AG), which prevents AGEs formation, inhibited the formation of intracellular Glycer-AGEs and prevented cell death. Among the intracellular Glycer-AGEs that were formed, heat shock cognate 70 (Hsc70) was identified as a GA-modified protein, and its modification reduced the activity of Hsc70. Furthermore, intracellular Glycer-AGEs increased the CRP mRNA concentration.
CONCLUSIONS: These results suggest that intracellular Glycer-AGEs play important roles in promoting inflammation and hepatocellular death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084527     DOI: 10.1007/s00535-009-0193-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  40 in total

1.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.

Authors:  P J Thornalley; A Langborg; H S Minhas
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

2.  Yeast protein glycation in vivo by methylglyoxal. Molecular modification of glycolytic enzymes and heat shock proteins.

Authors:  Ricardo A Gomes; Hugo Vicente Miranda; Marta Sousa Silva; Gonçalo Graça; Ana V Coelho; António E Ferreira; Carlos Cordeiro; Ana Ponces Freire
Journal:  FEBS J       Date:  2006-10-25       Impact factor: 5.542

3.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

4.  Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product (AGE)-induced C-reactive protein expression in hepatoma cells by suppressing Rac-1 activation.

Authors:  Takafumi Yoshida; Sho-ichi Yamagishi; Kazuo Nakamura; Takanori Matsui; Tsutomu Imaizumi; Masayoshi Takeuchi; Takato Ueno; Michio Sata
Journal:  FEBS Lett       Date:  2006-04-27       Impact factor: 4.124

5.  Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.

Authors:  Paulo S Ribeiro; Helena Cortez-Pinto; Susana Solá; Rui E Castro; Rita M Ramalho; Amélia Baptista; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

6.  Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.

Authors:  B Canbakan; H Senturk; V Tahan; I Hatemi; H Balci; T Toptas; A Sonsuz; M Velet; S Aydin; A Dirican; S Ozgulle; G Ozbay
Journal:  Acta Gastroenterol Belg       Date:  2007 Jul-Sep       Impact factor: 1.316

Review 7.  The multifaceted associations of hepatobiliary disease and diabetes.

Authors:  David S H Bell; Eric Allbright
Journal:  Endocr Pract       Date:  2007 May-Jun       Impact factor: 3.443

8.  Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction.

Authors:  M A Glomb; V M Monnier
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

Review 9.  The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions.

Authors:  Mads Daugaard; Mikkel Rohde; Marja Jäättelä
Journal:  FEBS Lett       Date:  2007-05-25       Impact factor: 4.124

10.  Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal.

Authors:  David L Carbone; Jonathan A Doorn; Zachary Kiebler; Brante P Sampey; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2004-11       Impact factor: 3.739

View more
  21 in total

1.  Glycation of the muscle-specific enolase by reactive carbonyls: effect of temperature and the protection role of carnosine, pyridoxamine and phosphatidylserine.

Authors:  Jadwiga Pietkiewicz; Agnieszka Bronowicka-Szydełko; Katarzyna Dzierzba; Regina Danielewicz; Andrzej Gamian
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

2.  In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM.

Authors:  Jun-ichi Takino; Kentaro Nagamine; Masayoshi Takeuchi; Takamitsu Hori
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 3.  Inflammation as death or life signal in diabetic fracture healing.

Authors:  Tamás Roszer
Journal:  Inflamm Res       Date:  2010-09-16       Impact factor: 4.575

Review 4.  Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Akiko Sakasai-Sakai; Takanobu Takata; Tadashi Ueda; Mikihiro Tsutsumi; Hideyuki Hyogo; Sho-Ichi Yamagishi
Journal:  World J Hepatol       Date:  2014-12-27

5.  Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products.

Authors:  Hayahide Ooi; Ryuto Nasu; Ayako Furukawa; Masayoshi Takeuchi; Yoshiki Koriyama
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

6.  Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro.

Authors:  Sean M Davidson; Jaime A Riquelme; Kaloyan Takov; Jose M Vicencio; Claire Boi-Doku; Vanessa Khoo; Christian Doreth; Dina Radenkovic; Sergio Lavandero; Derek M Yellon
Journal:  J Cell Mol Med       Date:  2017-08-25       Impact factor: 5.310

7.  Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion.

Authors:  Takanobu Takata; Tadashi Ueda; Akiko Sakasai-Sakai; Masayoshi Takeuchi
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

8.  The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.

Authors:  So Yeon Kong; Masayoshi Takeuchi; Hideyuki Hyogo; Gail McKeown-Eyssen; Sho-Ichi Yamagishi; Kazuaki Chayama; Peter J O'Brien; Pietro Ferrari; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Nadia Bastide; Franck Carbonnel; Tilman Kühn; Rudolf Kaaks; Heiner Boeing; Krasimira Aleksandrova; Antonia Trichopoulou; Pagona Lagiou; Effie Vasilopoulou; Giovanna Masala; Valeria Pala; Maria Santucci De Magistris; Rosario Tumino; Alessio Naccarati; H B Bueno-de-Mesquita; Petra H Peeters; Elisabete Weiderpass; J Ramón Quirós; Paula Jakszyn; María-José Sánchez; Miren Dorronsoro; Diana Gavrila; Eva Ardanaz; Martin Rutegård; Hanna Nyström; Nicholas J Wareham; Kay-Tee Khaw; Kathryn E Bradbury; Isabelle Romieu; Heinz Freisling; Faidra Stavropoulou; Marc J Gunter; Amanda J Cross; Elio Riboli; Mazda Jenab; W Robert Bruce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-24       Impact factor: 4.254

Review 9.  Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.

Authors:  Mona S Ottum; Anahita M Mistry
Journal:  J Clin Biochem Nutr       Date:  2015-07-01       Impact factor: 3.114

Review 10.  Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.

Authors:  Masayoshi Takeuchi
Journal:  Diagnostics (Basel)       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.